Dowling & Yahnke’s Viatris VTRS Stock Holding History

Dowling & Yahnke’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$102K	Sell	12,023 -865	-7%	-$8.51K	﹤0.01%	363
2022 Q2	$135K	Sell	12,888 -891	-6%	-$9.77K	0.01%	362
2022 Q1	$150K	Sell	13,779 -7,876	-36%	-$104K	0.01%	365
2021 Q4	$293K	Buy	21,655 +3,635	+20%	+$48.5K	0.01%	322
2021 Q3	$244K	Sell	18,020 -2,191	-11%	-$31.1K	0.01%	330
2021 Q2	$289K	Sell	20,211 -1,745	-8%	-$25.2K	0.02%	311
2021 Q1	$307K	Sell	21,956 -4,306	-16%	-$70.2K	0.02%	290
2020 Q4	$492K	Buy	+26,262	New	+$428K	0.04%	246
2015 Q3	–	Sell	-3,286	Closed	-$223K	–	268
2015 Q2	$223K	Buy	+3,286	New	+$232K	0.03%	245

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Dowling & Yahnke's VTRS Position: Q3 2022 in Review

Dowling & Yahnke reduced its Viatris (VTRS) stake by 6.7% in Q3 2022, selling an estimated $8.51K and leaving 12,023 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Dowling & Yahnke first reported a position in VTRS in Q2 2015 and has held it in 9 quarters since. The position peaked at $492K in Q4 2020. 982 funds tracked by Wall St. Rank hold VTRS as of Q3 2022.

Dowling & Yahnke held 12,023 shares of Viatris worth $102K as of Q3 2022.
Dowling & Yahnke sold 865 Viatris shares in Q3 2022, an estimated $8.51K.
Viatris made up ﹤0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #363 holding.
Dowling & Yahnke first reported a position in Viatris in Q2 2015 and has held it in 9 quarters since.
Dowling & Yahnke's Viatris position peaked at $492K in Q4 2020.
982 funds tracked by Wall St. Rank held Viatris as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.